These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 18457229)
21. Regulating drugs for effectiveness and safety: a public health perspective. Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264 [No Abstract] [Full Text] [Related]
22. Science and self-government. McClay WM New Atlantis; 2004; 4():17-22. PubMed ID: 15586960 [No Abstract] [Full Text] [Related]
23. Biogerontology, "anti-aging medicine," and the challenges of human enhancement. Juengst ET; Binstock RH; Mehlman M; Post SG; Whitehouse P Hastings Cent Rep; 2003; 33(4):21-30. PubMed ID: 12971058 [No Abstract] [Full Text] [Related]
24. US Food and Drug Administration regulations governing label claims for food products, including probiotics. Saldanha LG Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715 [TBL] [Abstract][Full Text] [Related]
25. Opposition in search of a rationale: the case for Food and Drug Administration regulation. Myers ML Tob Control; 2004 Dec; 13(4):441-3. PubMed ID: 15564634 [No Abstract] [Full Text] [Related]
26. Bioethics in wartime. Cohen E New Atlantis; 2003; 3():23-33. PubMed ID: 15586952 [No Abstract] [Full Text] [Related]
27. Drug review "behind the curtain": a response to Professor Struve. O'Reilly JT Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971 [No Abstract] [Full Text] [Related]
28. Generally Regarded As Safe. Novack GD Ocul Surf; 2017 Jan; 15(1):152-155. PubMed ID: 27871773 [No Abstract] [Full Text] [Related]
29. A millstone in the uphill battle for credibility. Czap A Altern Med Rev; 2001 Feb; 6(1):3. PubMed ID: 11207452 [No Abstract] [Full Text] [Related]
30. A proposal concerning products liability. Nusbaum NJ N Y State J Med; 1989 Jul; 89(7):396-9. PubMed ID: 2761867 [No Abstract] [Full Text] [Related]
31. The problem with the double-edged solution. Czap A Altern Med Rev; 2009 Jun; 14(2):96-8. PubMed ID: 19594219 [No Abstract] [Full Text] [Related]
32. The Lohr decision: FDA perspective and position. Porter MJ Food Drug Law J; 1997; 52(1):7-11. PubMed ID: 10346705 [No Abstract] [Full Text] [Related]
33. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction. Termini RB; Tressler L Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461 [No Abstract] [Full Text] [Related]
34. Toys and confectionery--a legally compatible combination. Degnan FH; Steinborn SB Food Drug Law J; 1998; 53(1):9-15. PubMed ID: 11795339 [No Abstract] [Full Text] [Related]
35. Going global. FDA moves to deal with growing raft of imports. Lee J Mod Healthc; 2011 Jun; 41(26):16. PubMed ID: 21853607 [No Abstract] [Full Text] [Related]
36. EU wrangles internally over safety of donated tissues and cells. Vermij P Nat Biotechnol; 2003 Dec; 21(12):1420. PubMed ID: 14647315 [No Abstract] [Full Text] [Related]
37. Counterfeiting and piracy of pharmaceuticals. Grackin A IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698 [No Abstract] [Full Text] [Related]
38. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division. Villafranco JE; Lustigman AB Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227 [No Abstract] [Full Text] [Related]
39. Animal cloning and food safety. Bren L FDA Consum; 2007; 41(2):32-5. PubMed ID: 17582865 [No Abstract] [Full Text] [Related]